TEM 📈 Tempus AI Class A Common - Overview

Tempus AI, Inc. is a healthcare technology company that specializes in providing advanced diagnostic testing and analytical services to various stakeholders in the healthcare and life sciences industries. The company's portfolio includes next-generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing. These services are designed to help healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties gain a deeper understanding of complex diseases and develop more effective treatments.

One of the key offerings of Tempus AI, Inc. is its Insights platform, which provides access to a vast library of de-identified clinical, molecular, and imaging data. This platform is licensed to pharmaceutical and biotechnology companies, which can leverage the data to inform their research and development efforts. Additionally, the company offers a suite of analytical services, including cloud-and-compute tools, to support the analysis and interpretation of complex data sets. The Trials platform is another notable offering, providing clinical trial matching services to pharmaceutical companies to help them identify suitable patients for their studies.

The company has developed a range of specialized tools and platforms to support its services, including Next, a suite of algorithmic tests in oncology, and Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results. The Lens platform is designed for researchers and scientists, providing a secure and user-friendly interface to access and analyze Tempus data. Through its collaboration with United Therapeutics, the company is exploring the use of AI to detect patients at risk for pulmonary hypertension, demonstrating its commitment to advancing the field of precision medicine.

As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol TEM, Tempus AI, Inc. is well-positioned to drive innovation and growth in the life sciences industry. With its roots dating back to 2015, the company has established itself as a leader in the development and application of AI-powered diagnostic testing and analytical services. Headquartered in Chicago, Illinois, Tempus AI, Inc. continues to push the boundaries of what is possible in healthcare and life sciences, with a strong focus on delivering actionable insights and driving better patient outcomes.